Literature DB >> 17982497

Adoptive cellular immunotherapy for viral diseases.

Y Fujita1, C M Rooney, H E Heslop.   

Abstract

Viral infections remain a major cause of morbidity and mortality after pediatric hematopoietic stem cell transplantation. Adoptive transfer of donor-derived virus-specific T cells can reconstitute antiviral immunity in recipients and be effective both in preventing and treating cytomegalovirus, Epstein-Barr virus and adenovirus infection. Current efforts are focused on providing protection toward a broader range of viruses safely, rapidly and effectively.

Entities:  

Mesh:

Year:  2007        PMID: 17982497     DOI: 10.1038/sj.bmt.1705906

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  29 in total

1.  Strategies to harness immunity against infectious pathogens after haploidentical stem cell transplantation.

Authors:  Sergio Rutella; Franco Locatelli
Journal:  Am J Transl Res       Date:  2011-09-10       Impact factor: 4.060

2.  Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience.

Authors:  Conrad Russell Cruz; Patrick J Hanley; Hao Liu; Vicky Torrano; Yu-Feng Lin; James A Arce; Stephen Gottschalk; Barbara Savoldo; Gianpietro Dotti; Chrystal U Louis; Ann M Leen; Adrian P Gee; Cliona M Rooney; Malcolm K Brenner; Catherine M Bollard; Helen E Heslop
Journal:  Cytotherapy       Date:  2010-10       Impact factor: 5.414

3.  Interleukin-7 permits Th1/Tc1 maturation and promotes ex vivo expansion of cord blood T cells: a critical step toward adoptive immunotherapy after cord blood transplantation.

Authors:  Craig C Davis; Luciana C Marti; Gregory D Sempowski; Durairaj A Jeyaraj; Paul Szabolcs
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

Review 4.  Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy.

Authors:  Pierre G Coulie; Benoît J Van den Eynde; Pierre van der Bruggen; Thierry Boon
Journal:  Nat Rev Cancer       Date:  2014-02       Impact factor: 60.716

5.  Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice.

Authors:  Christopher A Klebanoff; Luca Gattinoni; Douglas C Palmer; Pawel Muranski; Yun Ji; Christian S Hinrichs; Zachary A Borman; Sid P Kerkar; Christopher D Scott; Steven E Finkelstein; Steven A Rosenberg; Nicholas P Restifo
Journal:  Clin Cancer Res       Date:  2011-07-07       Impact factor: 12.531

Review 6.  Mouse models in bone marrow transplantation and adoptive cellular therapy.

Authors:  Caroline Arber; Malcolm K Brenner; Pavan Reddy
Journal:  Semin Hematol       Date:  2013-06-11       Impact factor: 3.851

7.  Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells.

Authors:  Laurent Boissel; Monica Betancur; Winfried S Wels; Hande Tuncer; Hans Klingemann
Journal:  Leuk Res       Date:  2009-01-14       Impact factor: 3.156

Review 8.  Induction/engineering, detection, selection, and expansion of clinical-grade human antigen-specific CD8 cytotoxic T cell clones for adoptive immunotherapy.

Authors:  Matjaz Jeras; Irena Bricl; Robert Zorec; Urban Svajger
Journal:  J Biomed Biotechnol       Date:  2010-03-10

9.  Phenotype and functional evaluation of ex vivo generated antigen-specific immune effector cells with potential for therapeutic applications.

Authors:  Shuhong Han; Yuju Huang; Yin Liang; Yuchin Ho; Yichen Wang; Lung-Ji Chang
Journal:  J Hematol Oncol       Date:  2009-08-06       Impact factor: 17.388

Review 10.  Chimeric antigen receptor-engineered T cells for immunotherapy of cancer.

Authors:  Marc Cartellieri; Michael Bachmann; Anja Feldmann; Claudia Bippes; Slava Stamova; Rebekka Wehner; Achim Temme; Marc Schmitz
Journal:  J Biomed Biotechnol       Date:  2010-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.